Accent Microcell Ltd
Incorporated in 2001, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Total Installed Capacity MTPA ・Standalone data |
|
|||
| Capacity Utilization - Dahej Plant % ・Standalone data |
||||
| Capacity Utilization - Pirana Plant % ・Standalone data |
||||
| Export Share of Revenue % ・Standalone data |
||||
| In-house Manufactured Goods Proportion % ・Standalone data |
||||
| Traded Goods Proportion % ・Standalone data |
||||
| Domestic Share of Revenue % ・Standalone data |
||||
| Number of Countries Presence Count ・Standalone data |
||||
| Number of MCC Grades Count ・Standalone data |
||||
| Top 10 Customer Revenue Concentration % ・Standalone data |
||||
| In-house Manufactured Volume MT ・Standalone data |
||||
| Pharma Segment Revenue Share % ・Standalone data |
||||
| Semi-processed/Traded Volume MT ・Standalone data |
||||
| Total Volume Sold MT ・Standalone data |
||||
| Unit I (Pirana) Capacity MTPA ・Standalone data |
||||
| Unit II (Dahej) Capacity MTPA ・Standalone data |
||||
| Unit III (Kheda) - Phase 1 Capacity MTPA ・Standalone data |
||||
Documents
Announcements
-
Updates
3 April 2026 - Accent Microcell Limited has informed regarding 'Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011'.
-
Press Release
26 March 2026 - CARE upgraded Accent Microcell to CARE A-; Stable and CARE A2+ on Mar 25, 2026.
-
Trading Window
25 March 2026 - Trading window closed from 01-Apr-2026 until 48 hours after board meeting for FY2025-26 audited results.
-
Credit Rating
18 March 2026 - CARE upgraded Accent Microcell to CARE A-/A2+ for bank facilities totalling ₹41.98 crore (18-Mar-2026).
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
5 January 2026 - Accent Microcell Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
Annual reports
Concalls
-
Aug 2025TranscriptPPTREC
-
May 2025Transcript PPT REC
-
Jan 2025TranscriptAI SummaryPPTREC
-
Mar 2024TranscriptAI SummaryPPTREC
Business Overview:[1]
AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to 10+ sectors and services 200+ customers in India and worldwide.